Chemoinformaics analysis of 5-METHOXY-1,7-DIPHENYLHEPTAN-3-ONE
| Molecular Weight | 296.41 | nRot | 9 |
| Heavy Atom Molecular Weight | 272.218 | nRig | 13 |
| Exact Molecular Weight | 296.178 | nRing | 2 |
| Solubility: LogS | -3.354 | nHRing | 0 |
| Solubility: LogP | 3.322 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 12 |
| nHA | 2 | APOL | 51.007 |
| nHD | 0 | BPOL | 26.681 |
| QED | 0.692 |
| Synth | 2.353 |
| Natural Product Likeliness | 1.119 |
| NR-PPAR-gamma | 0.856 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.993 |
| Pgp-sub | 0.406 |
| HIA | 0.003 |
| CACO-2 | -4.615 |
| MDCK | 0.0000188 |
| BBB | 0.807 |
| PPB | 0.96185 |
| VDSS | 0.751 |
| FU | 0.0131438 |
| CYP1A2-inh | 0.343 |
| CYP1A2-sub | 0.594 |
| CYP2c19-inh | 0.7 |
| CYP2c19-sub | 0.117 |
| CYP2c9-inh | 0.574 |
| CYP2c9-sub | 0.091 |
| CYP2d6-inh | 0.03 |
| CYP2d6-sub | 0.191 |
| CYP3a4-inh | 0.097 |
| CYP3a4-sub | 0.622 |
| CL | 10.759 |
| T12 | 0.753 |
| hERG | 0.5 |
| Ames | 0.095 |
| ROA | 0.035 |
| SkinSen | 0.705 |
| Carcinogencity | 0.267 |
| EI | 0.765 |
| Respiratory | 0.052 |
| NR-Aromatase | 0.048 |
| Antiviral | No |
| Prediction | 0.637844 |